Patents by Inventor Adam Scott Buntzman

Adam Scott Buntzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210047698
    Abstract: A method for diagnosing or monitoring an autoimmune disease, an immunity response post-vaccination, or a post-stem cell transplant reaction in a subject which includes high throughput T-Cell Receptor ? (TCR?) sequencing tests to identify dominant clone(s) in a subject suffering from the autoimmune disease, or in a subject post-vaccination administration, or in a subject post-stem cell transplantation. Oligonucleotides primer compositions and kits associated with the above-described methods are also provided herein. Said subject includes living organisms, such as mammals (e.g., dogs, cats, pigs, cows, horses, goats, rabbits, humans), non-mammalian vertebrates, such as birds (e.g., chicken, ducks), fish (e.g., sharks), or frogs, and transgenic species thereof.
    Type: Application
    Filed: November 2, 2020
    Publication date: February 18, 2021
    Applicant: KARKINOS PRECISION ONCOLOGY, LLC
    Inventor: Adam Scott Buntzman
  • Patent number: 10822662
    Abstract: A method for diagnosing a lymphoid proliferative disorder (such as lymphoma, T-cell lymphoma or leukemia) in a subject or determining the risk of a subject for a lymphoid proliferative disorder recurrence after transient remission, which includes high throughput T-Cell Receptor ? (TCR?) sequencing tests to identify dominant oncogenic clones in the subject suffering from the lymphoid proliferative disorder. Oligonucleotides primer compositions and kits associated with the above-described methods are also provided herein. Said subject includes living organisms, such as mammals (e.g., dogs, cats, pigs, cows, horses, goats, rabbits, humans), non-mammalian vertebrates, such as birds (e.g., chicken, ducks), fish (e.g., sharks), or frogs, and transgenic species thereof.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: November 3, 2020
    Assignee: Karkinos Precision Oncology LLC
    Inventor: Adam Scott Buntzman
  • Publication number: 20180258492
    Abstract: A method for diagnosing a lymphoid proliferative disorder (such as lymphoma, T-cell lymphoma or leukemia) in a subject or determining the risk of a subject for a lymphoid proliferative disorder recurrence after transient remission, which includes high throughput T-Cell Receptor ? (TCR?) sequencing tests to identify dominant oncogenic clones in the subject suffering from the lymphoid proliferative disorder. Oligonucleotides primer compositions and kits associated with the above-described methods are also provided herein. Said subject includes living organisms, such as mammals (e.g., dogs, cats, pigs, cows, horses, goats, rabbits, humans), non-mammalian vertebrates, such as birds (e.g., chicken, ducks), fish (e.g., sharks), or frogs, and transgenic species thereof.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Applicant: Karkinos Precision Oncology LLC
    Inventor: Adam Scott Buntzman